Your session is about to expire
← Back to Search
Terbinafine Gel for Toenail Fungus
Study Summary
This trial is testing a new gel to treat a type of fungal nail infection. The goal is to see if the gel is effective, safe, and well tolerated.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a fungal infection in at least one of my big toes.I am willing to not get pedicures, clip my nails, or use nail products on my toenails during the study.I haven't used antifungal treatments for nail or skin fungus in the last 3 months.My toe fungus was confirmed by lab tests.I do not have severe skin conditions like psoriasis or atopic dermatitis.My toe's condition or past surgeries might not allow full healing from a nail infection.My diabetes is under control.I am between 18 and 75 years old.I haven't taken oral antifungal medication in the last 6 months.I have not had a serious fungal infection or a condition that weakens my immune system.
- Group 1: HSG
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the patient recruitment for this investigation restricted to those under 75 years of age?
"This medical trial is open to individuals aged 18 years or older and younger than 75."
Do I meet the criteria necessary to participate in this experiment?
"This clinical trial is looking for 35 male and female participants aged 18-75 who have been clinically diagnosed with onychomycosis. As part of their inclusion criteria, these patients need to present with a distal lateral subungual involvement in at least one great toe as confirmed by KOH testing and fungal culture; they should also abstain from any pedicure, nail clipping or cosmetic treatments during the study period."
Has Hallux Terbinafine Subungual Gel been approved by the Food and Drug Administration?
"Hallux Terbinafine Subungual Gel is believed to be relatively safe, with a score of 2 assigned based on the Phase 2 trial's safety findings but lack of efficacy data."
Are there any ongoing enrollment opportunities for this experiment?
"Affirmative. Clinicaltrials.gov details that this scientific investigation, published on January 13th 2022, is presently recruiting participants. 35 individuals must be recruited from 3 different sites."
What is the current participation rate of this research project?
"This trial necessitates the enrolment of 35 eligible patients. For their convenience, they may choose to join at OrthoArizona - East Valley Foot & Ankle Specialists in Mesa, Arizona or J&S Studies in College Station, Texas."
Could you elucidate on prior investigations concerning Hallux Terbinafine Subungual Gel?
"Hallux Terbinafine Subungual Gel was first investigated during 2021 at Oregon Health & Science University. 25 studies have since been completed and presently, three trials are still in progress, with various sites located in Mesa, Arizona."
What diseases or conditions is Hallux Terbinafine Subungual Gel generally prescribed for?
"Hallux Terbinafine Subungual Gel is meant to manage fungal infections such as onychomycosis, severe tinea pedis and sporotrichosis."
Share this study with friends
Copy Link
Messenger